Blue Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Blue Trust's CRL Position: Q3 2026 in Review
Blue Trust increased its Charles River Laboratories (CRL) stake by 0.72% in Q3 2026, buying an estimated $5.53K and bringing the position to 2,958 shares worth $873K. The position accounts for 0.01% of the portfolio, ranked #326.
Blue Trust first reported a position in CRL in Q2 2022 and has held it in 18 quarters since. 515 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Blue Trust held 2,958 shares of Charles River Laboratories worth $873K as of Q3 2026.
- Blue Trust bought 21 Charles River Laboratories shares in Q3 2026, an estimated $5.53K.
- Charles River Laboratories made up 0.01% of Blue Trust's portfolio in Q3 2026, its #326 holding.
- Blue Trust first reported a position in Charles River Laboratories in Q2 2022 and has held it in 18 quarters since.
- 515 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.